AstraZeneca Pharma Ind Share Price

₹ 6,346.00

+₹1.00 (0.02%)
1D
Last updated 04 Nov, 2026, 13:00 IST
NSE: ASTRAZEN
|
Pharmaceuticals

AstraZeneca Pharma Ind Share Price Today

As of 4 Nov 2026, AstraZeneca Pharma Ind share price is ₹6,346.00. The stock opened at ₹6,391.50, compared to its previous close of ₹6,345.00. During today's trading session, AstraZeneca Pharma Ind share price moved in the range of ₹6,297.00 to ₹6,404.50, with an average price of ₹6,350.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹5,640.00 and a high of ₹9,849.50. On the performance front, AstraZeneca Pharma Ind share price has declined by 22.74% over the last six months and is down 35.44% on a year-on-year basis.

Share price over the last 1 day fell from 6404.50 to 6346.00, ranging between 6305.50 and 6404.50.
₹6,297.00
0.02% up today
₹6,404.50
1D LOW
1D HIGH

AstraZeneca Pharma Ind Stock Insights

Stock Performance
OutperformingBeat Nifty by 2.55 % in last 1 month
Shareholding Pattern
DIIDII increased stake by 12.57%
Shareholding Pattern
FIIFII decreased stake by 1.50%
AstraZeneca Pharma Ind stock performance
Open₹6,391.50
High₹6,404.50
Low₹6,297.00
Prev. close₹6,345.00
AstraZeneca Pharma Ind trading activity
Volume1,698
Average traded price₹6,356.07
Last traded time01:00:51 04 Nov
Last traded quantity1
Circuit
L
H
₹5,076.00
₹7,614.00
52-week
L
H
₹5,640.00
₹9,849.50
Mkt Cap Cr
15,708.13
P/E
93.45
P/B
18.16
ROA
8.53%
ROE
21.49%
ROCE
25.53%
Quick Ratio
0.73
EV/EBITDA
61.27

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Astrazeneca Phar outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Astrazeneca Phar appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,64,141.2490.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4784.09.64.7%11.42%11.37%0.7533.48
Laurus Labs1,26,811.2894.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,315.4045.25.827.82%12.76%14.68%0.7424.9
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,300.8316.574.114.47%23.76%24.88%1.429.76

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

AstraZeneca Pharma Ind Company Background

ISIN
INE203A01020
Sector Market Cap
₹ 15,708.13 Cr

AstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company’s DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).

AstraZeneca Pharma Ind Financial Highlights

  • Revenue: AstraZeneca Pharma Ind reported revenue of ₹2,304.07 crore in FY26 vs ₹1,756.92 crore in FY25. It showed an increase of 31.14% on a yearly basis.
  • Operating Profit: AstraZeneca Pharma Ind reported an operating profit of ₹252.20 crore in FY26 vs ₹156.36 crore in FY25. It showed an increase of 61.29% on a year-on-year basis.
  • Net Profit: AstraZeneca Pharma Ind reported a net profit of ₹187.52 crore in FY26 vs ₹115.74 crore in FY25. It showed an increase of 62.02% on a yearly basis.

AstraZeneca Pharma Ind Quarterly Result Highlights

  • AstraZeneca Pharma Ind reported revenue of ₹692.02 crore in Jun 2026, compared with ₹584.56 crore in Mar 2026, representing an increase of 18.38% on a quarter-on-quarter (QoQ) basis.
  • AstraZeneca Pharma Ind reported an operating profit of ₹50.75 crore in Jun 2026, compared with ₹58.14 crore in Mar 2026, representing a decrease of 12.71% on a quarter-on-quarter (QoQ) basis.
  • AstraZeneca Pharma Ind reported a profit of ₹37.93 crore in Jun 2026, compared with ₹44.88 crore in Mar 2026, reflecting a decrease of 15.49% on a QoQ basis.
  • The earnings per share (EPS) of AstraZeneca Pharma Ind stood at ₹75.01 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
75.00%
FII
2.64%
Other DII
0.08%
Retail and other
15.27%
Mutual funds
7.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.71%
Mar 20262.78%
Jun 20262.68%
Sep 20262.64%

AstraZeneca Pharma Ind Investment Returns

1 day
+0.85%
1 week
+4.48%
1 month
+5.21%
1 year
-35.44%
3 years
+35.99%
5 years
+111.23%

AstraZeneca Pharma Ind Share Price History

AstraZeneca Pharma Ind share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹6,373.50 / ₹6,345.00
+0.85%
02 Nov 26
₹6,353.00 / ₹6,291.50
-1.15%
30 Oct 26
₹6,300.00 / ₹6,364.50
+1.04%
29 Oct 26
₹6,185.50 / ₹6,299.00
+0.99%
Show more

AstraZeneca Pharma Ind Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,275.58₹1,716.29₹1,295.53₹1,002.97
Other Income₹28.49₹40.63₹34.80₹26.10
Total Revenue₹2,304.07₹1,756.92₹1,330.33₹1,029.07
Total Expenses₹2,046.62₹1,503.77₹1,127.22₹854.74
Profit Before Tax₹252.20₹156.36₹219.54₹134.10
Tax₹64.68₹40.62₹58.03₹34.81
Profit After Tax₹187.52₹115.74₹161.51₹99.29
EPS - Basic₹75.01₹46.30₹64.60₹39.70
EPS - Diluted₹75.01₹46.30₹64.60₹39.70

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹252.20₹156.36₹219.54₹134.10
Income before WC changes₹285.55₹232.77₹212.47₹129.30
Change in Assets-₹503.30-₹385.82-₹95.73-₹80.09
Change in Liabilities₹285.92₹282.60-₹32.44₹49.90
Change in WC-₹217.38-₹103.22-₹128.17-₹30.19
Cash flow from Operations-₹15.14₹65.36₹27.87₹58.29
Cash flow from Investing₹18.69₹30.80₹21.74₹18.11
Cash flow from Financing-₹91.97-₹65.59-₹44.38-₹24.48
Total Cash Flow-₹88.42₹30.57₹5.23₹51.92
Cash (Start of the year)₹536.14₹505.57₹500.34₹448.42
Cash (End of the year)₹447.72₹536.14₹505.57₹500.34

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹249.17₹175.77₹145.32₹149.40
Current Assets₹1,739.93₹1,342.35₹932.71₹835.47
Total Assets₹1,989.10₹1,518.12₹1,078.03₹984.87
Current Liabilities₹981.81₹703.00₹357.12₹383.93
Net Current Asset₹758.12₹639.35₹575.59₹451.54
Non-Current Liabilities₹134.50₹44.77₹8.99₹12.25
Equity Capital₹872.79₹770.35₹711.92₹588.69
Total Equity & Liabilities₹1,989.10₹1,518.12₹1,078.03₹984.87
* All values are in INR Crore
AstraZeneca Pharma Ind market depth
Bid quantityBid priceAsk priceAsk quantity
36352.56362.51
2635263631
36350.56364.54
16349.563661
16347.563671
Total bid quantity10
Total ask quantity8
AstraZeneca Pharma Ind technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
55.11
Neutral
ATR (14)
176.39
Neutral
STOCH(9,6)
82.49
Bearish
STOCH RSI (14)
94.25
Bearish
ADX(9)
40.3
Bearish
UO(9)
61.72
Neutral
ROC(12)
6.87
Bullish
WillR(14)
-17.07
Bearish
Period
Simple value
Exponential vaue
5D
6308.4
6286.58
10D
6183.55
6212.53
20D
6049.23
6195.29
50D
6473.31
6531.11
100D
7304.52
7063.81
Volume trend — traded volume by day
4 Nov0L
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

AstraZeneca Pharma Ind
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in AstraZeneca Pharma Ind

Fund name
AUM
Baroda BNP Paribas Health and Wellness Fund
4.07%
Bandhan Innovation Fund
3.90%
ICICI Prudential Quality Fund
2.84%

AstraZeneca Pharma Ind Returns Calculator

Ex-date: 31 Jul 2026

Top Gainers

GMDCLTD Share Price
₹466.00
+40.4 (+9.49%)
EQUITASBNK Share Price
₹56.96
+4.31 (+8.19%)
SAREGAMA Share Price
₹606.45
+44.25 (+7.87%)
LINDEINDIA Share Price
₹6272.50
+424 (+7.25%)
UNOMINDA Share Price
₹1199.60
+75.1 (+6.68%)
See more

Top Losers

SKFINDIA Share Price
₹1392.20
-79.7 (-5.41%)
AIAENG Share Price
₹3226.80
-162.9 (-4.81%)
ALKYLAMINE Share Price
₹1585.30
-73.5 (-4.43%)
ZYDUSLIFE Share Price
₹1191.00
-49.6 (-4%)
ASAHIINDIA Share Price
₹958.00
-33.45 (-3.37%)
See more

AstraZeneca Pharma Ind Share Price FAQs

Please be aware that AstraZeneca Pharma Ind stock prices are subject to continuous fluctuations due to various factors.